World

U.S. researchers develop eye drops slowing vision loss in animals

Mar 22, 2025

Los Angeles [California], March 22: Researchers at the U.S. National Institutes of Health (NIH) have developed eye drops that could slow vision loss in animals, the agency said on Friday.
The treatment shows potential to slow down the progression of human degenerative eye diseases, including retinitis pigmentosa, according to the study, published Friday in Communications Medicine.
The eye drops contain a small fragment derived from a protein made by the body and found in the eye, known as pigment epithelium-derived factor (PEDF). PEDF helps preserve cells in the eye's retina.
"While not a cure, this study shows that PEDF-based eye drops can slow progression of a variety of degenerative retinal diseases in animals, including various types of retinitis pigmentosa and dry age-related macular degeneration," said Patricia Becerra, chief of NIH's Section on Protein Structure and Function at the National Eye Institute, and senior author of the study.
"Given these results, we're excited to begin trials of these eye drops in people," Becerra said.
Source: Xinhua News Agency

More news

Nura Sleep Wins "Best Orthopaedic Mattress of the Year" at the House of Lords

London [UK], March 26: The award recognizes Nura Sleep's commitment to improving sleep quality through orthopaedic innovation and its strong impact on customer well-being. Bradford-based Nura Sleep, founded less than two years ago by director Mr. Mamit Agarwal, was awarded Best Orthopaedic Mattress of the Year at a ceremony held at the House of Lords. The company has rapidly established itself as a trusted brand in sleep solutions, addressing common issues such as back pain, neck stiffness, and poor sleep posture.

Mar 26, 2026